Biological Hydroxyapatite Bone Substitute - Vietnam Registration 2403347ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Biological Hydroxyapatite Bone Substitute in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2403347ĐKLH/BYT-HTTB and manufactured by CG Bio Co., Ltd.. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN DAEWOONG PHARMACEUTICAL CO., LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403347ĐKLH/BYT-HTTB
18007320/ĐKLH-BYT-TB-CT
Theo theo phụ lục
Theo phụ lục
Technical Details
The product is intended for the treatment of bone defects or bone deficiencies that are not related to the stability of the bone structure. ExcelOS Inject is indicated to fill bone defects and cavities of the skeletal system (such as the bones of the limbs, the spine, and the pelvis), and to fill and/or augment bone deficiencies in the mouth/mandible. The product provides a bone graft material that is capable of reabsorption and is replaced by bone during the healing process.
Dates and Status
Nov 06, 2024